Safety and effectiveness of neuraminidase inhibitors in situations of pandemic and/or novel/variant influenza: a systematic review of the literature, 2009-15
Boikos, C, Caya, C, Doll, M K, Kraicer-Melamed, H, Dolph, M, Delisle, G, Winters, N, Gore, G, Quach, C
Published in Journal of antimicrobial chemotherapy (01.06.2017)
Published in Journal of antimicrobial chemotherapy (01.06.2017)
Get full text
Journal Article
PCN52 BUDGET IMPACT OF SUBA-ITRACONAZOLE CAPSULES (SUBA-ITRA) FOR THE TREATMENT OF SYSTEMIC MYCOSES IN THE U.S
Tremblay, G., Westley, T., Dolph, M., Newman, D., Lewis, G.
Published in Value in health (01.05.2019)
Published in Value in health (01.05.2019)
Get full text
Journal Article
PSY19 - USING A BAYESIAN NETWORK META-ANALYSIS (NMA) TO COMPARE FERRIC MALTOL TO TREATMENTS FOR IRON DEFICIENCY AND IRON DEFICIENCY ANAEMIA EXCLUDING CHF AND CKD PATIENTS
Jones, T., Forsythe, A., Sampson, M., Tremblay, G., Dolph, M.
Published in Value in health (01.10.2018)
Published in Value in health (01.10.2018)
Get full text
Journal Article
CN6 - COST-EFFECTIVENESS MODEL OF MIDOSTAURIN (MIDO) VERSUS STANDARD OF CARE (SOC) IN PATIENTS WITH NEWLY DIAGNOSED FLT3 MUTATION-POSITIVE (FLT3+) ACUTE MYELOID LEUKEMIA (AML): A FRENCH PERSPECTIVE
Cariou, C., Tremblay, G., Dolph, M., Brandt, P.S., Forsythe, A.
Published in Value in health (01.10.2018)
Published in Value in health (01.10.2018)
Get full text
Journal Article
PSY217 - INCREMENTAL QUALITY-ADJUSTED SURVIVAL ANALYSIS WHEN NO HEAD TO HEAD DATA ARE AVAILABLE: A CASE STUDY OF MIDOSTAURIN (MIDO) VERSUS STANDARD OF CARE (SOC) IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS (ASM)
Cariou, C., Tremblay, G., Dolph, M., Brandt, P.S., Forsythe, A.
Published in Value in health (01.10.2018)
Published in Value in health (01.10.2018)
Get full text
Journal Article